NASDAQ:ALXN
Delisted

Alexion Pharmaceuticals Stock News

etoro logo Buy ALXN
*Your capital is at risk
$182.50
+0 (+0%)
At Close: May 27, 2022
In a report released today, Raju Prasad from William Blair maintained a Buy rating on Rocket Pharmaceuticals (RCKT – Research
ULTOMIRIS® (ravulizumab) Receives Marketing Authorization from European Commission for Adults and Children with Atypical Hemolytic Uremic Syndrome
La nueva edición hablará del futuro turístico de Córdoba y de los problema de los profesores de Religión
These time-tested growth stocks won't bat an eye if stock market volatility returns.
These time-tested growth stocks won't bat an eye if stock market volatility returns.
Biotech stocks went on a seesaw ride along with the broader markets in the week ended June 26. Yet there were some encouraging developments on the COVID-19 vaccine development...
La nueva edición hablará del patrimonio de Córdoba y de los nuevos destinos para sacerdotes de la diócesis
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive th
APG Asset Management N.V. lifted its position in shares of Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) by 185.9% during the 1st quarter, according to its most recent filing with the Securities and Exc
Se hablará de las rebajas y la reapertura de los cines, además del fallecimiento de otra persona por Covid-19
Este sábado nuestro periódico además informará sobre los rebrotes de coronavirus y cómo será la regulación del teletrabajo, entre otros temas
Gilead's (GILD) experimental coronavirus drug, remdesivir, has been recommended for approval by the EMA's human medicines committee.
El periódico llevará amplia informacion sobre la participación de Javier Cercas en el Foro Cultural de ABC
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE